CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - USD ($) $ in Thousands	Total	Series A	Series B	Series C	IPO	Private Placement	Follow-on offering	Common Stock	Common Stock IPO	Common Stock Private Placement	Common Stock Follow-on offering	Additional Paid In Capital	Additional Paid In Capital IPO	Additional Paid In Capital Private Placement	Additional Paid In Capital Follow-on offering	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2021	$ (121,515)							$ 1				$ 8,615				$ (130,111)	$ (20)
Beginning Balance, Shares at Dec. 31, 2021								544,210
Temporary Equity, Beginning Balance at Dec. 31, 2021		$ 28,894	$ 85,367	$ 119,118
Temporary Equity, Beginning balance, shares at Dec. 31, 2021		5,413,272	8,975,585	10,396,707
Issuance of common stock, net of transaction costs, value					$ 127,283	$ 9,958			$ 9	$ 1			$ 127,274	$ 9,957
Issuance of common stock , net of transaction costs, shares									9,487,500	590,318
Conversion of preferred stock to common stock, value	233,379							$ 25				233,354
Conversion of preferred stock to common stock, shares								24,785,564
Temporary Equity, Conversion of stock, value		$ (28,894)	$ (85,367)	$ (119,118)
Temporary Equity, Conversion of stock, shares		(5,413,272)	(8,975,585)	(10,396,707)
Issuance of common stock from vesting of restricted stock units, value	107											107
Issuance of common stock from vesting of restricted stock units, shares								24,889
Exercise of stock options, value	307											307
Exercise of stock options, shares								286,283
Share-based compensation	4,481											4,481
Unrealized gain (loss) on marketable securities	(24)																(24)
Net loss	(26,041)															(26,041)
Ending Balance at Mar. 31, 2022	227,935							$ 36				384,095				(156,152)	(44)
Ending Balance, shares at Mar. 31, 2022								35,718,764
Beginning Balance at Dec. 31, 2021	(121,515)							$ 1				8,615				(130,111)	(20)
Beginning Balance, Shares at Dec. 31, 2021								544,210
Temporary Equity, Beginning Balance at Dec. 31, 2021		$ 28,894	$ 85,367	$ 119,118
Temporary Equity, Beginning balance, shares at Dec. 31, 2021		5,413,272	8,975,585	10,396,707
Net loss	(56,813)
Ending Balance at Jun. 30, 2022	323,619							$ 44				510,761				(186,924)	(262)
Ending Balance, shares at Jun. 30, 2022								43,782,058
Beginning Balance at Mar. 31, 2022	227,935							$ 36				384,095				(156,152)	(44)
Beginning Balance, Shares at Mar. 31, 2022								35,718,764
Issuance of common stock, net of transaction costs, value							$ 120,719				$ 8				$ 120,711
Issuance of common stock , net of transaction costs, shares											8,050,000
Issuance of common stock from vesting of restricted stock units, value	11											11
Issuance of common stock from vesting of restricted stock units, shares								13,294
Share-based compensation	5,944											5,944
Unrealized gain (loss) on marketable securities	(218)																(218)
Net loss	(30,772)															(30,772)
Ending Balance at Jun. 30, 2022	323,619							$ 44				510,761				(186,924)	(262)
Ending Balance, shares at Jun. 30, 2022								43,782,058
Beginning Balance at Dec. 31, 2022	204,954							$ 44				523,921				(318,790)	(221)
Beginning Balance, Shares at Dec. 31, 2022								44,105,981
Issuance of common stock in accordance with Gilead Stock Purchase Agreement, shares	115,270							$ 4				115,266
Issuance of common stock in accordance with Gilead Stock Purchase Agreement, value								3,478,261
Issuance of common stock from vesting of restricted stock units, shares								222,433
Exercise of stock options, value	374											374
Exercise of stock options, shares								34,713
Share-based compensation	10,156											10,156
Unrealized gain (loss) on marketable securities	307																307
Net loss	(27,344)															(27,344)
Ending Balance at Mar. 31, 2023	303,717							$ 48				649,717				(346,134)	86
Ending Balance, shares at Mar. 31, 2023								47,841,388
Beginning Balance at Dec. 31, 2022	204,954							$ 44				523,921				(318,790)	(221)
Beginning Balance, Shares at Dec. 31, 2022								44,105,981
Net loss	(51,198)
Ending Balance at Jun. 30, 2023	293,667							$ 48				663,614				(369,988)	(7)
Ending Balance, shares at Jun. 30, 2023								48,315,391
Beginning Balance at Mar. 31, 2023	303,717							$ 48				649,717				(346,134)	86
Beginning Balance, Shares at Mar. 31, 2023								47,841,388
Issuance of common stock from vesting of restricted stock units, shares								46,593
Issuance of common stock pursuant to employee stock purchase plan, value	528											528
Issuance of common stock pursuant to employee stock purchase plan, Shares								28,549
Exercise of stock options, value	2,965											2,965
Exercise of stock options, shares								398,861
Share-based compensation	10,404											10,404
Unrealized gain (loss) on marketable securities	(93)																(93)
Net loss	(23,854)															(23,854)
Ending Balance at Jun. 30, 2023	$ 293,667							$ 48				$ 663,614				$ (369,988)	$ (7)
Ending Balance, shares at Jun. 30, 2023								48,315,391